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themhad upper respiratory infection due to congested and dusty environment. On
previous observation may of hajj pilgrims were given antibiotic for their URTIs.
Most of antibiotics prescribed to pilgrimswere based onprescribers judgments.The
study aims to determine the prevalence severity and the pattern of antibiotic
usage. METHODS: This cross sectional study was conducted from December 2007
to January 2008. Validated self administered questionnaire forms were distributed
to about 3,000 Malaysian Hajj Pilgrims in Makkah of Saudi Arabia. The severity of
URTIs was based on the patient’s perception and the number of symptoms.
RESULTS: Majority, 87.1% of 2194 pilgrims reported had URTIs, 12.4%, (41.6%) and
(46.0%) of pilgrims were categorised severe, moderate, and mild respectively. An-
tibiotics were prescribed to 58.8% pilgrims, the pattern of antibiotic used was as-
sociated with severity (p 0.001) and the number of symptoms(p 0.001)and 55.1%
of them had fever. Many of them(68.8%), take one course of antibiotic, while 28.5 %
and 8.0% received two and three causes. CONCLUSIONS: A high prevalence of
URTIs was found among Malaysian Hajj Pilgrims. Most of the pilgrims with mod-
erate to severe and had fever received antibiotics. About one third of them, how-
ever,were not get benefit fromfirst course of antibiotics. Proper antibiotic guideline
that supported by microbiological studies are proposed to justify the use of antibi-
otics for hajj pilgrims.
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OBJECTIVES: To evaluate the use of sedatives in critically ill adult patients with
endotracheal tube (ETT) and mechanical ventilator (MV) in a hospital in Taiwan.
METHODS:We conducted the study retrospectively by reviewing medical records.
All patients with ICD-9, 96.71, 96.72, 96.04, fromOct 2008 to Feb 2009were included.
Patients were excluded if they were pediatric patients, without complete records,
using MV after discharged, in regular wards, or using MV less than 24 hours. The
primary end point is the duration of mechanical ventilation. The secondary end
points were length of ICU stay, hospital stay and events of tracheostomy, reintu-
bation, self-extubation. Chi square and t-test were performed for dichotomous and
continuous variables respectively. SPSS (Version 13.0) was used. The data were log
transformed to address the non-normal distribution. RESULTS: We collected 50
events of insertion of endotracheal tube with mechanical ventilator (ETTMV) in
using sedatives group and 163 in not using group. The duration of mechanical
ventilation was not significantly difference between two groups. (p 0.582) The
using sedatives group had longer ICU (p 0.04) and hospital length of stay (p
0.001). There were much more patients were physically restricted in the using
sedatives group (84% vs. 56%). The usages of sedatives were 50% ofmidazolam and
54% of propofol. The mean treatment duration among patients receiving midazo-
lam was 4.6 days and 2.2 days among patients with propofol. This longer duration
of length of stayswere possibly related to the usage ofmidazolamand the prescrib-
ing habits of physicians. CONCLUSIONS: We found the physician preference by
using physical restriction as first line and sedatives as second line did not benefit
the critically ill patients.Wewill implement a sedation guideline to tailor the needs
of our facility for optimal the patient care.
PHP110
REAL-WORLD DIAGNOSIS AND TREATMENT PATTERNS OF IRON DEFICIENCY
ANEMIA IN CHINA
Liu B1, Hao J2, Li Z3, Nie X4, Tang M1, Gao Y3, Yang H1, Hu S5
1School of Public Health, Fudan University, Shanghai, China, 2Vifor Pharma Ltd., Glattbrugg,
Switzerland, 3Shanghai Centennial Scientific Co., Ltd., Shanghai, China, 4Bloomberg School of
Public Health, Johns Hopkins University, Baltimore, MD, USA, 5Shanghai Health Development
Research Center, Shanghai, China
OBJECTIVES: To investigate the real-world diagnosis and treatment patterns of
iron deficiency anemia (IDA) in China. METHODS: Literature review, Key Opinion
Leaders survey, and patient case reviewwere conducted. The reviewwas based on
China Academic Journals Full-text Database (2006-2010). A total of 163 publications
were targeted by searching in terms of IDA diagnosis and treatment. A total of 44
senior physicians specialized in nephrology, hematology and obstetrics/gynecol-
ogy were selected from tertiary hospitals in Beijing, Shanghai, Guangzhou, She-
nyang and Chengdu, who were requested to complete a questionnaire in two
weeks. The structured questionnaire included IDA awareness, diagnosis, treat-
ment and related drivers and restrictions. Information on Lab tests and treatments
were collected from 91 patient cases. Descriptive analysis was performed. The
results of KOL survey and patient case review were consistent, indicating the va-
lidity of the results. RESULTS: IDA wasmost likely found in patients in nephrology
and obstetrics/gynecology, and in patients with chronic kidney disease on hemo-
dialysis. Seventy-five percent of nephrologists, 58% of hematologists, and 25% of
obstetricians/gynecologists reported the existence of hospital-wide guidelines for
IDA diagnosis and treatment, respectively. Lab tests and cut-off for IDA diagnosis
varied across different specialties and different physicians in the same specialty.
Intravenous (IV) ironwasmore effective and caused less side effects than oral iron.
IV iron sucrose increased hemoglobin level faster and greater than intramuscular
iron dextran. Nephrologists usually prescribed IV iron as the first line, while hema-
tologists and obstetricians/gynecologists preferred oral iron. Price was not the
most influential driver for using IV iron. Fifty-seven percent of KOLs, however,
reported the restrictions of IV iron use due to cost.CONCLUSIONS:Guideline-based
diagnosis and treatment for IDA needs to be strengthened in China. Real-world
prescription of IV iron for IDA varied across specialties andmay be restricted due to
cost despite its better effectiveness.
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OBJECTIVES: To develop national medicine brand substitution guidelines and as-
sessment of its adoptability among community pharmacist and general practitio-
ners in Malaysia.METHODS: A cross sectional postal survey was conducted with a
sample of 100 community pharmacists and 100 general practitioners selected sys-
tematically in the state of Penang, Malaysia. A pre validated questionnaire was
used for data collection. Frequencies and percentages were used to elaborate the
data. SPSS v. 16 was used for data analysis. RESULTS: From a total of 200 question-
naires mailed, the response rate was 16% (n16) for general practitioners and 36%
(n36) for community pharmacist. Majority of the respondents (n53, 85.4%) dis-
agreed that generic medicines lead to more side effect as compared to innovator
brands. However, 59.6% (n37) reported that Innovator brands are more effective
than genericmedicines. Moreover, (n33, 53.2%) agreed that genericsmedicine are
not bioequivalent to the innovator brands. Majority (n40, 64.5%) stated that ge-
nericmedicines should be available in samedosage formand strength as innovator
brand medicines. Almost all respondents (n52, 83.8%) demanded that dispensed
medicines should be labelled with the generic (INN) name of the medicine with or
without the brand name. While comparing with general physicians (n13, 81.3%),
community pharmacists (n33, 91.7%) were in high favor that a written national
generic brand substitution guideline is needed in Malaysia. In addition, all of the
respondents strongly agreed to the statement that thorough counselling should be
provided to the patients if their medicine is changed from innovator brand to
generic in order to avoid confusion. CONCLUSIONS: Majority of general practitio-
ners and community pharmacists in Penang agreed to the contents of the draft
national medicine brand substitution guideline. This is a good indicator that the
contents can actually be the foundation of an actual national medicine brand sub-
stitution guideline.
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OBJECTIVES: SMBG is one of the core components of diabetes therapy. It supports
a safe and effective drug therapy and provides additional feedback on howdiet and
lifestyle impact blood glucose levels. In 2011 a Chinese guideline on SMBG was
published. SMBG, in contrast to most diabetes drugs, is not reimbursed. This study
aims to assess the level of SMBG usage in patients on different diabetes therapies.
METHODS: 1st half year 2011 data (10,418 cases) from the CSD PDS Diabetes survey
were used for this explorative analysis. PDS Diabetes is a syndicated research with
a fixed representative panel of endocrinologists and cardiologists from 13 large
Chinese cities. Patient cases are documented in a standardized format. SMBGusage
was analyzed by therapy-subgroups: oral diabetes therapy only (OAD 54%), basal
supported oral therapy (BOT 18%), conventional insulin therapy (CT 20%), intensive
insulin therapy (IIT 6%) and OTHERS (2% - not reported). RESULTS: Ninety-five
percent were patients with type 2 diabetes. A total of 5288 patients (50.8%) had a
meter for home-testing. Shares of testers by therapies (OAD / BOT / CT / IIT) were
34.7%, 60.1%, 53.4% and 48.4%. Average weekly test frequencies were 2.8, 3.3, 3.0
and 4.0 respectively. In the IIT group 1% tested at least 3 times a day. HbA1c levels
were by 0.2%, 0.5%, 0.4% and 1.2% lower in SMBG users. CONCLUSIONS:High share
of patients don’t have a meter to perform SMBG at home. For testers with BOT, CT
and IIT test-frequencies remained clearly below the Chinese guideline recom-
mending 10, 10 and 21 test per week respectively. For IIT (SMBG is needed to
support insulin dose adjustments) only 1% tested at the guideline-recommende
frequency. In IIT patients differences in HbA1 were largest between testers and
non-testers. Further research is needed to clarify if e. g. education or reimburse-
ment could potentially resolve these shortfalls.
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OBJECTIVES:Utilization of fasting plasma glucose (FPG), HbA1c and SMBG are con-
sidered core components of diabetes therapy. They support a safe and effective
drug therapy and they provide feedback on the quality of glycemic control. In
2011 a Chinese guideline on SMBG was published. SMBG, in contrast to most dia-
betes drugs, is not reimbursed in China. This study aims to assess the level of SMBG
usage with patients on different diabetes therapies in community health centers
(primary care). METHODS: In 2012 a survey was conducted in community health
centers in 6 districts of Shanghai. 935 random diabetes cases were documented in
a standardized format. Subsequent explorative analysis were performed. SMBG
usage was analyzed by therapy-subgroups: oral diabetes therapy only (OAD 84%),
any therapy involving insulin (INSULIN 14%) and OTHERS (2%). RESULTS: 99%were
patients with type 2 diabetes. FPG levels were available for 86% and 89% in OAD/
INSULIN respectively, HbA1c levelswere available for 32.0% and 19.4% respectively.
For 124 patients (13.3%) SMBG usage was reported, for 111 of them actual test
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